Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Diagnostics Neurology, Omics, Screening and monitoring, Software and hardware

In the Blood

Autism spectrum disorder (ASD) is currently diagnosed based on behavioral assessment, but such assessments can be difficult to administer to younger children. The average child is diagnosed with ASD at four or five years old – but identifying children with ASD when they are toddlers may lead to more effective intervention and treatment. Many studies using blood-based biomarkers have been difficult to replicate. How can we overcome this challenge? Machine learning might just be the answer.

A proteomic analysis of serum from boys with and without ASD – aged 18 months to eight years – has used machine learning to incorporate demographic and clinical data into the analysis, aiming to improve predictive power (1). Using three different algorithms to examine over 1,100 proteins, researchers identified a panel of nine proteins that not only differentiated boys with ASD from those without, but also correlated with ASD severity.

A blood-based panel of proteins could provide a simple method for early identification of ASD. Though it’s still early days for machine learning in ASD diagnosis, the future looks promising. Integrating the technology into clinical datasets could help identify toddlers at risk, confirm diagnosis, or guide individualized treatment plans. “Ideally, there will be a day when a child is identified using blood biomarkers as being at risk for developing ASD and therapies can be started immediately,” said Dwight German, senior author on the study (2). “That would help the child develop skills to optimize their communication and learning.”

Subscribe to The Pathologist Newsletters

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].

  1. L Hewitson et al., PLoS One, 16, e0246581 (2021). PMID: 33626076.
  2. UT Southwestern (2021). Available at: http://bit.ly/3tlStO1.

About the Author

Olivia Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

Related Application Notes

Biomarker Optimization on LabSat® Research

| Contributed by Lunaphore Technologies

Fast and automated TSA-based multiplexed immunofluorescence on LabSat® Research

| Contributed by Lunaphore Technologies

Specific Detection of RNA Expression and Distribution in Brain Using RNAscope® Technology

| Contributed by ACD

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register